Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Stevenson

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Physiology|December 1, 1991
Regulation of glucose metabolism by norepinephrine in conscious dogsC C Connolly, K E Steiner, R W Stevenson, et al.
Diabetes|May 20, 1998
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptideW C Soeller, J Janson, S E Hart, et al.
The Journal of Clinical Investigation|April 1, 1995
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)E M Gibbs, J L Stock, S C McCoid, et al.
Diabetes/Metabolism Reviews|January 1, 1987
Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivoA D Cherrington, R W Stevenson, K E Steiner, et al.
Diabetes|March 15, 2001
GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cureJ T Brozinick, S C McCoid, T H Reynolds, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 23, 1999
Structure-function analysis of a series of glucagon-like peptide-1 analogsJ C Parker, K M Andrews, D M Rescek, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivoW H Martin, D J Hoover, S J Armento, et al.
Diabetes|March 1, 1987
Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivoR W Stevenson, K E Steiner, M A Davis, et al.
Diabetes|January 1, 1996
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat dietR W Stevenson, R K McPherson, L M Persson, et al.
Journal of Medicinal Chemistry|January 1, 1991
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agentsD A Clark, S W Goldstein, R A Volkmann, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Physiology|December 1, 1991
Regulation of glucose metabolism by norepinephrine in conscious dogsC C Connolly, K E Steiner, R W Stevenson, et al.
Diabetes|May 20, 1998
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptideW C Soeller, J Janson, S E Hart, et al.
The Journal of Clinical Investigation|April 1, 1995
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)E M Gibbs, J L Stock, S C McCoid, et al.
Diabetes/Metabolism Reviews|January 1, 1987
Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivoA D Cherrington, R W Stevenson, K E Steiner, et al.
Diabetes|March 15, 2001
GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cureJ T Brozinick, S C McCoid, T H Reynolds, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 23, 1999
Structure-function analysis of a series of glucagon-like peptide-1 analogsJ C Parker, K M Andrews, D M Rescek, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivoW H Martin, D J Hoover, S J Armento, et al.
Diabetes|March 1, 1987
Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivoR W Stevenson, K E Steiner, M A Davis, et al.
Diabetes|January 1, 1996
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat dietR W Stevenson, R K McPherson, L M Persson, et al.
Journal of Medicinal Chemistry|January 1, 1991
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agentsD A Clark, S W Goldstein, R A Volkmann, et al.
Pageof 9